Pulmonary MicroRNA Changes Alter Angiogenesis in Chronic Obstructive Pulmonary Disease and Lung Cancer

Area of Science:

• Pulmonary medicine
• Molecular biology
• Oncology

Background:

• Pulmonary endothelium dysfunction is observed in chronic obstructive pulmonary disease (COPD), a risk factor for lung cancer.
• Emphysema, a component of COPD, shows altered pulmonary endothelium and increased cancer incidence.
• Gene and microRNA expression profiles differ between COPD and non-COPD lung tissues.

Purpose of the Study:

• To investigate the hypothesis that altered microRNA expression in the pulmonary endothelium contributes to its dysfunction in COPD.
• To compare microRNA expression in endothelial cells from COPD and non-COPD patients.
• To assess the functional impact of specific microRNAs on endothelial cell behavior relevant to emphysema and lung cancer.

Main Methods:

• Endothelial cells were isolated from healthy lung and tumor tissues of 28 patients undergoing pulmonary resection.
• MicroRNA expression was compared between COPD and non-COPD patient groups.
• Quantitative polymerase chain reaction (qPCR) validated findings. Angiogenesis and cellular migration assays were performed on human umbilical vein endothelial cells transfected with microRNA mimics.

Main Results:

• Expression of miR-181b-3p, miR-429, and miR-23c was significantly increased in COPD patients (p < 0.05).
• Overexpression of miR-181b-3p led to reduced endothelial sprouting.
• miR-429, also overexpressed in lung cancer, reduced tubular formation in vitro.

Conclusions:

• MicroRNA-driven alterations in the pulmonary endothelium represent a novel mechanism contributing to emphysema.
• These microRNA-mediated processes may offer potential therapeutic targets for both COPD and lung cancer.
• Further research is warranted to explore the therapeutic potential of targeting these microRNA pathways.